Table 2.

Intra-hospital outcome

	eGFR < 15 mL/min	eGFR 15–29 mL/min	eGFR 30–59 mL/min	No CKD	p value for trend*
Total cohort, n (% of all patients)	15 (2.4)	45 (7.2)	239 (38.4)	324 (52.0)
MACCE, n (%)	0 (0.0)	2 (4.4)	0 (0.0)	1 (0.3)	0.097
Death, n (%)	0 (0.0)	2 (4.4)	0 (0.0)	0 (0.0)	0.028
Myocardial infarction, n (%)	0 (0.0)	0 (0.0)	0 (0.0)	1 (0.3)	0.62
Stroke, n (%)	0 (0.0)	0 (0.0)	0 (0.0)	1 (0.3)	0.62
Other major complication, n (%)	2 (13.3)	2 (4.4)	10 (4.2)	12 (3.7)	0.27
Severe bleeding, n (%)	1 (6.7)	0 (0.0)	3 (1.3)	3 (0.9)	0.43
AV fistula or pseudoaneurysm, n (%)	0 (0.0)	1 (2.2)	2 (0.8)	3 (0.9)	1.0
Pericardial effusion requiring action, each n (%)
Surgery	0 (0.0)	0 (0.0)	0 (0.0)	2 (0.6)	0.38
Intervention	1 (6.7)	1 (2.2)	5 (2.1)	6 (1.9)	0.44
Device dislodgement requiring action, each n (%)
Surgery	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	–
Additional intervention	1 (6.7)	0 (0.0)	1 (0.4)	0 (0.0)	0.028
Moderate complications, n (%)	4 (26.7)	5 (11.1)	20 (8.4)	29 (9.0)	0.18
Moderate bleeding, n (%)	1 (6.7)	2 (4.4)	2 (0.8)	6 (1.9)	0.4
TIA, n (%)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	–
Successful cardiopulmonary resuscitation, n (%)	0 (0.0)	0 (0.0)	1 (0.4)	2 (0.6)	0.71
Access site infection, n (%)	0 (0.0)	0 (0.0)	1 (0.4)	0 (0.0)	1.0
Pericardial effusion with conservative treatment, n (%)	0 (0.0)	0 (0.0)	4 (1.7)	7 (2.2)	0.31
Device dislodgement handled by immediate retraction, n (%)	0 (0.0)	0 (0.0)	3 (1.3)	2 (0.6)	1.0

AV arteriovenous, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, MACCE major adverse cardiac and cerebrovascular events, TIA transitory ischemic attack

^*Tested by exact Cochran–Armitage test; p < 0.05 is indicating a significant difference (printed in bold type)